FDA investigation into fake medicine network intensifies, collecting patient data

The Food and Drug Administration (FDA) has advanced its investigation into the fake medicine network. Officials are collecting information on where the fake medicines were supplied and gathering data on the patients who consumed them. The FDA is collecting details regarding the purchase and usage of medicines from hospitals' pharmacies, including the date, hospital, and quantity used. Officials are also gathering details on the batch, hospital, and pharmacy where the medicine was given to patients.